Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
The Business Journals20h
Health Care Innovation Awards: Central City Concern
Portland’s biggest homeless services provider attempts to solve the problem of caring for a highly mobile, in-need population ...
Grondahl: The durable healer of the North Country
Dr. John Rugge is a gifted writer and canoeist but he will be remembered as the architect of the Adirondacks' rural primary ...
The Nation Newspaper1d
Unpacking the 2024 Joint Annual Health Review meeting
One of the high points of the JAR meeting was the presentation by the National Primary Health Care Development Agency (NPHCDA ...